Diane E. Wilfong - 10 Jun 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Interim Corp Controller & CAO
Signature
/s/ Edward S. Son by Power of Attorney for Diane E. Wilfong
Issuer symbol
GILD
Transactions as of
10 Jun 2025
Net transactions value
-$37,431
Form type
4
Filing time
11 Jun 2025, 19:10:19 UTC
Previous filing
20 Mar 2025
Next filing
11 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wilfong Diane E. Interim Corp Controller & CAO GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Diane E. Wilfong 11 Jun 2025 0001374988

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +920 +2% 46,016 10 Jun 2025 Direct F1
transaction GILD Common Stock Tax liability $37,431 -340 -0.74% $110.09 45,676 10 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -920 -9.5% 8,785 10 Jun 2025 Common Stock 920 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.